Of designer drugs, magic bullets, and gold standards

JAMA. 1998 May 13;279(18):1483-5. doi: 10.1001/jama.279.18.1483.
No abstract available

Publication types

  • Comment
  • Editorial

MeSH terms

  • Cardiovascular Diseases / epidemiology*
  • Estrogen Antagonists / therapeutic use*
  • Estrogen Replacement Therapy*
  • Estrogens / agonists*
  • Humans
  • Piperidines / therapeutic use*
  • Raloxifene Hydrochloride
  • Risk Factors
  • Tamoxifen / therapeutic use*

Substances

  • Estrogen Antagonists
  • Estrogens
  • Piperidines
  • Tamoxifen
  • Raloxifene Hydrochloride